Skip to content

AI Model for Assessing Cardiac Surgeons' Techniques

artifiCiAl Intelligence Model for Evaluating the Surgical Techniques of caRdiAc Surgeons (CAMERA)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06739005
Acronym
CAMERA
Enrollment
284
Registered
2024-12-18
Start date
2025-01-09
Completion date
2027-07-31
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence (AI), CABG, CABG-patients, Cardiovascular Surgery, Surgeons

Brief summary

The goal of this study aims to investigate the use of artificial intelligence to analyze and evaluate the characteristics and proficiency of surgeons during vascular anastomosis in coronary artery bypass grafting (CABG) procedures. The main question it aims to answer is: Consistency assessment between AI evaluation scores and human expert evaluation scores for surgeons during left anterior descending (LAD) artery anastomosis.

Interventions

None listed

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Undergoing internal mammary artery-to-left anterior descending artery bypass grafting * First-time recipient of isolated CABG surgery * Signed written informed consent

Exclusion criteria

* Patients with acute coronary syndrome * Patients with contraindications to coronary CT angiography or coronary angiography * Patients with renal insufficiency or active liver disease, including those with persistently elevated serum transaminases of unknown cause or any serum transaminase levels exceeding three times the upper limit of normal.

Design outcomes

Primary

MeasureTime frame
Consistency assessment between AI surgical evaluation scores and human expert scores.At the end of enrollment

Secondary

MeasureTime frameDescription
Intraoperative measurement of graft flow and flow resistance.After enrollment
Characteristics of the surgeon's motion trajectory.After enrollment
Consistency assessment between AI surgical evaluation scores levels and human expert scores levels.After enrollmentAI surgical evaluation scores levels were divided into the following 3 score levels: low, middle, high; human expert scores levels were divided into the following 3 score levels: low, middle, high.

Other

MeasureTime frameDescription
Surgeon-level subgroup: sexBaselineSex subgroup is stratified into: female, male
Surgeon-level subgroup: professional titleBaselineProfessional title subgroup is stratified into: junior, associate, senior
Surgeon-level subgroup: annual surgery volumeBaselineAnnual surgery volume subgroup is stratified by tertiles
Surgeon-level subgroup: total surgery volumeBaselineTotal surgery volume subgroup is stratified by tertiles
Graft patency at 1 year postoperatively.At 1 year
Surgeon-level subgroup: total CABG volumeBaselineTotal CABG volume subgroup is stratified by tertiles
Patient-level subgroup: ageBaselineAge subgroup is stratified into: \<65, ≥65 years old
Patient-level subgroup: sexBaselineSex subgroup is stratified into: female, male
Patient-level subgroup: the severity of coronary artery diseaseBaselineThe severity of coronary artery disease is measured by SYNTAX score and is stratified into: \<23, 23-32, \>32
Surgeon-level subgroup: annual CABG volumeBaselineAnnual CABG volume subgroup is stratified by tertiles
Adverse cardiovascular events, such as myocardial infarction and stroke, within 6 months postoperatively.At 6 months
Adverse cardiovascular events, such as myocardial infarction and stroke, within 12 months postoperatively.At 12 months
Surgeon-level subgroup: ageBaselineAge subgroup is stratified into: \<45, ≥45 years old

Countries

China

Contacts

Primary ContactLihua Zhang, M.D, Ph.D
zhanglihua@fuwai.com8613641359895

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026